Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6914)
All Articles published online
|
Publishing Process of This Article
|
Oct 14, 2017 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hamdani S, Thiolat A, Naserian S, Grondin C, Moutereau S, Hulin A, Calderaro J, Grimbert P, Cohen JL, Azoulay D, Pilon C. Delayed and short course of rapamycin prevents organ rejection after allogeneic liver transplantation in rats. World J Gastroenterol 2017; 23(38): 6962-6972 [PMID: 29097869 DOI: 10.3748/wjg.v23.i38.6962] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v23/i38/6962.htm |
| Number | Citing Articles |
| 1 |
Sina Naserian, Mathieu Leclerc, Sara Shamdani, Georges Uzan. Current Preventions and Treatments of aGVHD: From Pharmacological Prophylaxis to Innovative Therapies. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.607030
|
| 2 |
Farhana Afroz, Els Jonkman, Jin Hua, Alwyn Kist, Yabin Zhou, Elke M. Sokoya, Robert Padbury, Vincent Nieuwenhuijs, Greg Barritt. Evidence that decreased expression of sinusoidal bile acid transporters accounts for the inhibition by rapamycin of bile flow recovery following liver ischemia. European Journal of Pharmacology 2018; 838: 91 doi: 10.1016/j.ejphar.2018.08.043
|
| 3 |
Hai Liu, Huangrong Zhu, Liang Cheng, Yitao Zhao, Xizhong Chen, Jintao Li, Xin Xv, Zhisheng Xiao, Wei Li, Jianying Pan, Qun Zhang, Chun Zeng, Jinshan Guo, Denghui Xie, Daozhang Cai. TCP/PLGA composite scaffold loaded rapamycin in situ enhances lumbar fusion by regulating osteoblast and osteoclast activity. Journal of Tissue Engineering and Regenerative Medicine 2021; 15(5): 475 doi: 10.1002/term.3186
|
| 4 |
Li Long, Mulin Liang, Yanling Liu, Pan Wang, Hongxing Dang. OSI-027 alleviates rapamycin insensitivity by modulation of mTORC2/AKT/TGF-β1 and mTORC1/4E-BP1 signaling in hyperoxia-induced lung injury infant rats. Molecular & Cellular Toxicology 2021; 17(3): 245 doi: 10.1007/s13273-021-00131-y
|
| 5 |
Hao Wang, Ruining Yang, Zhenglu Wang, Lei Cao, Dejun Kong, Qian Sun, Sei Yoshida, Jiashu Ren, Tao Chen, Jinliang Duan, Jianing Lu, Zhongyang Shen, Hong Zheng. Metronomic capecitabine with rapamycin exerts an immunosuppressive effect by inducing ferroptosis of CD4+ T cells after liver transplantation in rat. International Immunopharmacology 2023; 124: 110810 doi: 10.1016/j.intimp.2023.110810
|
| 6 |
Haitao Li, Saihua Yu, Haiyan Liu, Lihong Chen, Hongzhi Liu, Xingwen Liu, Conglong Shen. Immunologic barriers in liver transplantation: a single-cell analysis of the role of mesenchymal stem cells. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1274982
|
| 7 |
Rosanna Salvia, Marisa Nardiello, Carmen Scieuzo, Andrea Scala, Sabino A. Bufo, Asha Rao, Heiko Vogel, Patrizia Falabella. Novel Factors of Viral Origin Inhibit TOR Pathway Gene Expression. Frontiers in Physiology 2018; 9 doi: 10.3389/fphys.2018.01678
|
| 8 |
Xinle Wang, Sonya A. MacParland, Catia T. Perciani. Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model. Transplantation 2021; 105(9): 1944 doi: 10.1097/TP.0000000000003598
|
| 9 |
Kayalvizhi Madhivanan, Swetha Ramadesikan, Wen-Chieh Hsieh, Mariana C Aguilar, Claudia B Hanna, Robert L Bacallao, R Claudio Aguilar. Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins. Human Molecular Genetics 2020; 29(10): 1700 doi: 10.1093/hmg/ddaa086
|
| 10 |
Andreas Schroeter, Maximilian J. Roesel, Tomohisa Matsunaga, Yao Xiao, Hao Zhou, Stefan G. Tullius. Aging Affects the Role of Myeloid-Derived Suppressor Cells in Alloimmunity. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.917972
|
| 11 |
Basant A. Abdulrahman, Waqas Tahir, Katsumi Doh-Ura, Sabine Gilch, Hermann M. Schatzl. Combining autophagy stimulators and cellulose ethers for therapy against prion disease. Prion 2019; 13(1): 185 doi: 10.1080/19336896.2019.1670928
|
| 12 |
Jordi Ochando, Patricia Conde, Alberto Utrero-Rico, Estela Paz-Artal. Tolerogenic Role of Myeloid Suppressor Cells in Organ Transplantation. Frontiers in Immunology 2019; 10 doi: 10.3389/fimmu.2019.00374
|
| 13 |
Alejandro J. Nicola Candia, Matías Garcia Fallit, Jorge A. Peña Agudelo, Melanie Pérez Küper, Nazareno Gonzalez, Mariela A. Moreno Ayala, Emilio De Simone, Carla Giampaoli, Noelia Casares, Adriana Seilicovich, Juan José Lasarte, Flavia A. Zanetti, Marianela Candolfi. Targeting FOXP3 Tumor-Intrinsic Effects Using Adenoviral Vectors in Experimental Breast Cancer. Viruses 2023; 15(9): 1813 doi: 10.3390/v15091813
|
| 14 |
Hui Zhang, Qi-Wei Li, Yuan-Yuan Li, Xue Tang, Ling Gu, Han-Min Liu. Myeloid-derived suppressor cells and pulmonary hypertension. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1189195
|